Six-year follow-up of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis: MRI outcomes from DEFINE, CONFIRM and ENDORSE

被引：0
|
作者：
Arnold, D. L. [1 ,2 ]
Fox, R. J. [3 ]
Gold, R. [4 ]
Havrdova, E. [5 ]
Kappos, L. [6 ]
Yousry, T. [7 ]
MacManus, D. [7 ]
Zhang, R. [8 ]
Yang, M. [8 ]
Rana, J. [8 ]
机构：
[1] McGill Univ, NeuroRx Res, Montreal, PQ, Canada
[2] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada
[3] Cleveland Clin, Mellen Ctr Multiple Sclerosis Treatment & Res, Cleveland, OH 44106 USA
[4] Ruhr Univ Bochum, St Josef Hosp, Bochum, Germany
[5] Charles Univ Prague, Dept Neurol, Fac Med 1, Prague, Czech Republic
[6] Univ Basel Hosp, Basel Neurol, CH-4031 Basel, Switzerland
[7] UCL, Inst Neurol, Queen Sq Multiple Sclerosis Ctr, NMR Res Unit, London, England
[8] Biogen Inc, Cambridge, MA 02142 USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2015年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P566
引用
收藏
页码：264 / 265
页数：2
相关论文
共 50 条
  • [41] Longer-term follow-up of the efficacy of delayed-release dimethyl fumarate in newly diagnosed patients with RRMS: an integrated analysis of DEFINE, CONFIRM, and ENDORSE
    Marantz, J.
    Gold, R.
    Giovannoni, G.
    Phillips, J. T.
    Fox, R. J.
    Zhang, A.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 263 - 263
  • [42] Efficacy of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: integrated analysis of the phase 3 trials
    Viglietta, Vissia
    Miller, David
    Bar-Or, Amit
    Phillips, J. Theodore
    Arnold, Douglas L.
    Selmaj, Krzysztof
    Kita, Mariko
    Hutchinson, Michael
    Yang, Minhua
    Zhang, Ray
    Dawson, Katherine T.
    Sheikh, Sarah I.
    Fox, Robert J.
    Gold, Ralf
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2015, 2 (02): : 103 - 118
  • [43] Budget impact analysis of delayed-release dimethyl-fumarate in the treatment of relapsing-remitting multiple sclerosis in Italy
    Furneri, Gianluca
    Marchesi, Chiara
    Santoni, Laura
    FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2016, 17 (01) : 29 - 39
  • [44] Efficacy of Delayed-Release Dimethyl Fumarate in Newly Diagnosed Patients with Relapsing-Remitting Multiple Sclerosis Using a Composite Measure of Disability: Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies
    Phillips, J. Theodore
    Bar-Or, Amit
    Gold, Ralf
    Giovannoni, Gavin
    Fox, Robert
    Potts, James
    Soman, Teesta
    Marantz, Jing
    NEUROLOGY, 2016, 86
  • [45] Effects of Delayed-Release Dimethyl Fumarate (DMF) on Health-Related Quality of Life in Patients With Relapsing-Remitting Multiple Sclerosis: An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies
    Kita, Mariko
    Fox, Roberti
    Gold, Ralf
    Giovannoni, Gavin
    Phillips, J. Theodore
    Sarda, Sujata P.
    Kong, Jessica
    Viglietta, Vissia
    Sheikh, Sarah I.
    Okwuokenye, Macaulay
    Kappos, Ludwig
    CLINICAL THERAPEUTICS, 2014, 36 (12) : 1958 - 1971
  • [46] Delayed-release dimethyl fumarate and health-related quality of life (HRQoL) in relapsing-remitting multiple sclerosis (RRMS) patients according to prior therapy: integrated analysis of DEFINE and CONFIRM
    Kappos, L.
    Fox, R. J.
    Gold, R.
    Kita, M.
    Phillips, J. T.
    Sarda, S. P.
    Zhong, L.
    Niecko, T.
    Kurukulasuriya, N. C.
    Giovannoni, G.
    JOURNAL OF NEUROLOGY, 2014, 261 : S306 - S306
  • [47] Delayed-release dimethyl fumarate and health-related quality of life (HRQoL) in relapsing-remitting multiple sclerosis (RRMS) patients according to prior therapy: integrated analysis of DEFINE and CONFIRM
    Kappos, L.
    Fox, R. J.
    Gold, R.
    Kita, M.
    Phillips, J. T.
    Sarda, S. P.
    Zhong, L.
    Niecko, T.
    Kurukulasuriya, N. C.
    Giovannoni, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 462 - 462
  • [48] Delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis - findings from a real-world setting in Russian Federation
    Davydovskaya, M.
    Pozhidaeva, N.
    Dubchenko, E.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 934 - 935
  • [49] Six-year follow-up of relapsing-remitting multiple sclerosis patients with interferon-β-1b treatment
    Mátyás, K
    Bencsik, K
    Füvesi, J
    Rajda, G
    Fricska-Nagy, Z
    Komoly, S
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S246 - S247
  • [50] Oral BG-12 (dimethyl fumarate) for relapsing-remitting multiple sclerosis: a review of DEFINE and CONFIRM
    Havrdova, Eva
    Hutchinson, Michael
    Kurukulasuriya, Nuwan C.
    Raghupathi, Kartik
    Sweetser, Marianne T.
    Dawson, Katherine T.
    Gold, Ralf
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (15) : 2145 - 2156
12345